Safety evaluation of a short-term infusion of ramucirumab for GI tract cancer patients
Not Applicable
- Conditions
- Gastric and colorectal cancer
- Registration Number
- JPRN-UMIN000029318
- Lead Sponsor
- Aichi Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe respiratory or cardiovascular diseases 2. Need for dose reduction of ramucirumab 3. Past history of infusion related reaction (grade3 or more) due to chemotherapeutic agents 4. Past history of infusion related reaction (any grade) due to ramucirumab 5. Daily use of antiallergic agents or steroids due to allergic diseases 6. Inadequate conditions, as diagnoses by the primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method